首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Will Chinese external therapy with compound Tripterygium wilfordii hook F gel safely control disease activity in patients with rheumatoid arthritis: design of a double-blinded randomized controlled trial
【2h】

Will Chinese external therapy with compound Tripterygium wilfordii hook F gel safely control disease activity in patients with rheumatoid arthritis: design of a double-blinded randomized controlled trial

机译:中药复方雷公藤钩F凝胶的外用疗法能否安全控制类风湿关节炎患者的疾病活动:双盲随机对照试验的设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundChinese external therapy (CET) is a topical application with mainly Chinese herb medicine therapy with thousands of years of historical implications and is a clinical routine that is commonly used for relieving joint-related symptoms in patients with arthritis in Chinese hospitals. However, there is a paucity of modern medical evidence to support its effectiveness and safety. Thus, we propose to implement a randomized, double-blinded, placebo-controlled clinical trial in patients with rheumatoid arthritis (RA) using, as the experimental intervention, topical application of a hospital-compounded gel preparation of Tripterygium wilfordii Hook F (TwHF).
机译:背景技术中药外用疗法(CET)是一种局部疗法,主要用于中草药疗法,具有数千年的历史意义,是一种临床常规方法,通常用于缓解中国医院关节炎患者的关节相关症状。但是,缺乏现代医学证据来支持其有效性和安全性。因此,我们建议对风湿性关节炎(RA)患者进行局部,随机,双盲,安慰剂对照的临床试验,方法是使用雷公藤雷公藤钩F(TwHF)医院复合凝胶制剂的局部应用作为实验干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号